Search results for #BMFsm
Very excited to speak at the Taiwan Society of Blood and Marrow Transplantation and Hematology Society of Taiwan joint annual meeting 🇹🇼 on immunosuppressive therapies for #SAA. Met some wonderful new colleagues, have seen beautiful sights and had excellent hospitality. #BMFsm
Interesting results from colleague Andre LaRochelle using eltrombopag in patients with #Fanconi Anemia. Good hematologic responses seen! @nih_nhlbi @aamdsif #BMFsm
Great talk from my @nih_nhlbi colleague @DrDavidJYoung who presented data on medical therapies for #DBA. #BMFsm @aamdsif. He is running a new clinical trial using bitopertin (glyT1 inhibitor). @cedunbar80
Excellent talk from our @nih_nhlbi clinical fellow @1JibranDurrani at @aamdsif showcasing our pre-clinical work using JAKi in immune #BMFsm. Clinical trial @nih_nhlbi using Ruxolitinib now open! @NealSYoung1 @bhavishap29
My @nih_nhlbi colleague @fergutierrezro1 gives an excellent overview @aamdsif of our machine learning model to predict immune from inherited #AplasticAnemia. #BMFsm
@aamdsif scientific symposium starting now! Excited for a great day of #BMFsm and #PNH talks! @nih_nhlbi @NealSYoung1
Check out this session next week (moderated by my colleague @bhavishap29 and @Olson__Lab) at the @aamdsif symposium where our @nih_nhlbi fellow @1JibranDurrani will discuss our work using JAKi in immune marrow failure. Clinical trial enrolling now! clinicaltrials.gov/study/NCT05998… #BMFsm
Check out this session next week (moderated by my colleague @bhavishap29 and @Olson__Lab) at the @aamdsif symposium where our @nih_nhlbi fellow @1JibranDurrani will discuss our work using JAKi in immune marrow failure. Clinical trial enrolling now! clinicaltrials.gov/study/NCT05998… #BMFsm
Happy #InternationalWomensDay to my amazing clinical and scientific colleagues in the @nih_nhlbi #BMFsm team! A👩🔬strong team paving the way in #SAA #Telomere disorders #VEXAS and more🧬🩸@bhavishap29 @fergutierrezro1 @TheBethesdaLabs
Glad to see SOAR trial now available @TheLancetHaem. Investigators looked at ATG-free therapy with CSA and EPAG. Response rates inferior to triple therapy but good option if ATG not available/contraindicated. Congrats to all involved! @scheinbp #BMFsm #SAA thelancet.com/journals/lanha…
Very interesting paper just out in @BloodJournal from @ChariteBerlin and other German collaborators looking at the role of viral infections 🦠 in driving the t-cell mediated destruction of hematopoietic stem cells seen in #SAA. #BMFsm ashpublications.org/blood/article-…
Excited to see the new @BritSocHaem guidelines for #AplasticAnemia are now available in @BrJHaem. Very useful for any haematologists treating AA patients! #BMFsm #SAA onlinelibrary.wiley.com/doi/10.1111/bj…
We are now recruiting patients for our @nih_nhlbi @TheBethesdaLabs clinical trial using Ruxolitinib in relapsed or refractory immune #BMFsm. Includes #SAA, #MAA, #PRCA, #TLGL and hypoplastic #MDSsm. See below for more details and DM me if any questions! clinicaltrials.gov/study/NCT05998… 👩🔬
Our @nih_nhlbi clinical trial using Ruxolitinib in relapsed / refractory #BMFsm is now accepting referrals! Includes #SAA, #MAA, #PRCA, #LGL and hypoplastic #MDSsm. See details: clinicaltrials.gov/study/NCT05998… @1JibranDurrani @bhavishap29 @NealSYoung1 2/2
A good end to 2023 🎆- our paper looking at low-dose Ruxolitinib + CSA in 🐭 #BMFsm now available in @Haematologica. We found that toxicity in mice primary affects 🩸red blood cells and low dose combo therapy is effective. @nih_nhlbi @NealSYoung1 haematologica.org/article/view/h… 1/2👇
Vote for our lovely 🐭 marrow, rescued from aplasia! @BloodJournal #BMFsm
Vote for our lovely 🐭 marrow, rescued from aplasia! @BloodJournal #BMFsm https://t.co/OcY7d9KwXh
Interesting talk from Carlos Bravo-Perez @ClevelandClinic on the incidence of inborn errors of immunity on #BMFsm. @ASH_hematology #ASH23
Come check out @bhavishap29’s poster reporting the interim analysis of our @nih_nhlbi phase 2 study utilizing early initiation of CSA and eltrombopag for #SAA. #BMFsm @aamdsif #ASH23 @NealSYoung1